Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Hematology/Oncology Clinics of North America|October 23, 1997
Treatment considerations in the elderly patient with lymphomaJ M Connors, S E O'ReillyLeukemia & Lymphoma|January 1, 1993
Is there a role for MACOP-B in the treatment of diffuse large cell lymphoma?S E O'Reilly, J M ConnorsCancer|January 1, 1991
The evolving role of etoposide in the management of lymphomas and Hodgkin's diseaseS E O'Reilly, P Klimo, J M ConnorsJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphomaS E O'Reilly, P Klimo, J M ConnorsAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's diseaseS E O'Reilly, P Hoskins, P Klimo, et al.Clinics in Geriatric Medicine|May 1, 1997
Malignant lymphomas in the elderlyS E O'Reilly, J M Connors, N Macpherson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-BA Y Lee, J M Connors, P Klimo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapyS E O'Reilly, J M Connors, S Howdle, et al.Blood|May 15, 1991
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988A Lohri, M Barnett, R N Fairey, et al.Canadian Family Physician Medecin De Famille Canadien|January 22, 2011
Malignant lymphomas: their diagnosis, treatment and prognosisS E O'ReillyPageof 16